Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine.

Literature DB >> 12085015

Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine.

Michael M Friedlaender, Dvora Rubinger, Eli Rosenbaum, Gail Amir, Edgar Siguencia.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 12085015 DOI： 10.1097/00007890-200206150-00028

Source DB: PubMed Journal: Transplantation ISSN： 0041-1337 Impact factor: 4.939

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma.

Authors: Dirk Schadendorf; Paul Nghiem; Shailender Bhatia; Axel Hauschild; Philippe Saiag; Lisa Mahnke; Subramanian Hariharan; Howard L Kaufman
Journal: Oncoimmunology Date: 2017-08-31 Impact factor: 8.110

2. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.

Authors: Rikke Lyngaa; Natasja Wulff Pedersen; David Schrama; Charlotte Albæk Thrue; Dafina Ibrani; Ozcan Met; Per Thor Straten; Paul Nghiem; Jürgen C Becker; Sine Reker Hadrup
Journal: Clin Cancer Res Date: 2014-02-13 Impact factor: 12.531

3. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.

Authors: Michelle Heath; Natalia Jaimes; Bianca Lemos; Arash Mostaghimi; Linda C Wang; Pablo F Peñas; Paul Nghiem
Journal: J Am Acad Dermatol Date: 2008-03 Impact factor: 11.527

4. An unusual case of Merkel cell carcinoma.

Authors: Eva-Susanne Strobel; Petra Feyer; Maria Steingräber; Annette Schmitt-Gräff; Peter Karl Kohl
Journal: J Cancer Res Clin Oncol Date: 2007-07-25 Impact factor: 4.553

Review 5. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.

Authors: Natalie Vandeven; Paul Nghiem
Journal: Immunotherapy Date: 2016-07 Impact factor: 4.196

6. Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.

Authors: Mitra Dowlatshahi; Victor Huang; Ahmed E Gehad; Ying Jiang; Adam Calarese; Jessica E Teague; Andrew A Dorosario; Jingwei Cheng; Paul Nghiem; Carl F Schanbacher; Manisha Thakuria; Chrysalyne D Schmults; Linda C Wang; Rachael A Clark
Journal: J Invest Dermatol Date: 2013-02-18 Impact factor: 8.551

Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine.

Review 1. Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma.

2. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.

3. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.

4. An unusual case of Merkel cell carcinoma.

Review 5. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.

6. Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.

Review 7. Does a new polyomavirus contribute to Merkel cell carcinoma?

8. Diagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma.

Review 9. Skin cancer in kidney transplant recipients.

10. The role of the immune response in merkel cell carcinoma.